Company News

Symrise Takes Stake in U.S. BioTech Firm

Symrise has acquired a 20% stake Therapeutic Peptides Inc. (TPI), a New Orleans, LA-based biotechnology company, giving it exclusive distribution rights for advanced cosmetic active ingredients, including peptides.

“We are delighted to be able to integrate these modern and very effective ingredients in our portfolio. With TPI, we have found a partner who is developing these ingredients at a scientifically exalted level and can offer ample expertise in this field,” said Dr. Klaus Stanzl, president, scent and care, Life Essentials.

More info: www.symrise.com

Add us as a preferred source on Google

Get the latest Happi news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Happi Newsletters